Andressa Ardiani

发表

Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.

B. Stoddard, A. Korkegian, M. Black, 2008, Journal of molecular biology.

Engineering novel suicide enzymes for improved cancer gene therapy

Andressa Ardiani, 2009 .

Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway

Andressa Ardiani, R. Donahue, J. Hodge, 2014, Oncotarget.

Cancer Therapy : Preclinical Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model

Andressa Ardiani, A. Protter, Zhimin Guo, 2013 .

Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model

Andressa Ardiani, A. Protter, Zhimin Guo, 2013, Clinical Cancer Research.

The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

Andressa Ardiani, J. Hodge, S. Gameiro, 2012, Seminars in oncology.

Vaccines based on whole recombinant Saccharomyces cerevisiae cells.

Andressa Ardiani, J. Higgins, J. Hodge, 2010, FEMS yeast research.

Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens

Andressa Ardiani, J. Hodge, S. Gameiro, 2014, Oncoimmunology.

Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.

B. Stoddard, M. Black, Andressa Ardiani, 2009, Cancer research.

Fusion Enzymes Containing HSV-1 Thymidine Kinase Mutants and Guanylate Kinase Enhance Prodrug Sensitivity In Vitro and In Vivo

M. Black, Andressa Ardiani, Marilyn Sánchez-Bonilla, 2009, Cancer Gene Therapy.

Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.

M. Black, Andressa Ardiani, Hongmei Ruan, 2012, Current gene therapy.

Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin

Andressa Ardiani, Jacob Richards, J. Hodge, 2016, Oncotarget.

Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.

J. Schlom, Andressa Ardiani, J. Hodge, 2014, Cancer research.

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine

J. Schlom, Andressa Ardiani, J. Hodge, 2013, Oncotarget.

Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine

Andressa Ardiani, R. Donahue, J. Hodge, 2014, Journal of Translational Medicine.

A poxviral-based cancer vaccine targeting the transcription factor Twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model

Andressa Ardiani, J. Hodge, U. Dirmeier, 2015, Oncotarget.

Comparative Analysis of Enzyme and Pathway Engineering Strategies for 5FC-Mediated Suicide Gene Therapy Applications

M. Black, Andressa Ardiani, Marilyn Sanchez-Bonilla, 2011, Cancer Gene Therapy.

Mutations at serine 37 in mouse guanylate kinase confer resistance to 6-thioguanine.

M. Black, Andressa Ardiani, Amanda Goyke, 2009, Protein engineering, design & selection : PEDS.

Attacking malignant cells that survive therapy

Andressa Ardiani, J. Hodge, S. Gameiro, 2013, Oncoimmunology.

The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

Andressa Ardiani, J. Hodge, B. Farsaci, 2012, Seminars in oncology.